Description
Tyrosinase (369-377) is a tumor antigenic peptide produced by the proteasome that has been used to develop tumor-targeted vaccines with mixed efficacy.
Product Unit Size | Cost | Quantity | Stock |
---|
Tyrosinase (369-377) is a tumor antigenic peptide produced by the proteasome that has been used to develop tumor-targeted vaccines with mixed efficacy.
Cas No. | 9002-10-2 |
---|---|
Purity | ≥95% |
Formula | C42H66N10O16S2 |
Formula Wt. | 1031.2 |
Solubility | Soluble in water. |
Store Temp | -20°C |
---|---|
Ship Temp | Ambient |
MSDS | |
---|---|
Info Sheet |
Guillaume B, Stroobant V, Bousquet-Dubouch MP, et al. Analysis of the processing of seven human tumor antigens by intermediate proteasomes. J Immunol. 2012 Oct 1;189(7):3538-47. PMID: 22925930.
Mitchell MS, Darrah D, Yeung D, et al. Phase I trial of adoptive immunotherapy with cytolytic T lymphocytes immunized against a tyrosinase epitope. J Clin Oncol. 2002 Feb 15;20(4):1075-86. PMID: 11844833.
Peptide, involved in neutrophil activation; FPR...
Aminoglycoside; protein translation inhibitor, ...
Progesterone derivative; Cyp17A1 inhibitor.
Nucleoside (thymidine) analog; DNA chain termin...
Nucleoside (thymidine) analog.
Aminocoumarin; bacterial DNA gyrase inhibitor.<...
V2 antagonist.
Casein kinase 1α/δ/ε inhibitor.
Carbapenem β-lactam; penicillin binding protei...
Aminoglycoside; protein translation inhibitor.<...
Synthetic derivative of vasicine, mucolytic.
PKC and PKD activator, carcinogen.
Mixture found in Croton, used to induce inflamm...
pan-PI3K inhibitor.
5-HT2 antagonist, SERT and NET inhibitor, hERG ...
Cyclosporin metabolite; weak calmodulin inhibit...
Mycotoxin produced by Penicillum, Aspergillus, ...
Fluoroquinolone; bacterial DNA gyrase inhibitor...
FIASMA, σ1, RyR2, TrkA/B agonist; SERT, NET in...
Used to study embryonic cloning; microtubule po...